Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy

Case report

(2361) Views  (776) Full article downloads

Authors: Grimelda Yuriana Sánchez-Castro, Alejandra Hitos-Fájer, Erick Mendoza-Schuster, Raul Velez-Montoya, Cecilio Francisco Velasco-Barona

Published Date October 2008 Volume 2008:2(3) Pages 657 - 660

DOI: http://dx.doi.org/10.2147/OPTH.S2686

Grimelda Yuriana Sánchez-Castro¹, Alejandra Hitos-Fájer¹, Erick Mendoza-Schuster¹, Raul Velez-Montoya², Cecilio Francisco Velasco-Barona¹

¹Asociación para Evitar la Ceguera en México. Hospital “Dr. Luis Sánchez Bulnes”, México, D.F. Ophthalmology Department – Anterior Segment; ²Asociación para Evitar la Ceguera en México. Hospital “Dr. Luis Sánchez Bulnes”, México, D.F. Ophthalmology Department – Retina department

Abstract: We reported a 75-year-old diabetic man, who developed opacification and neovascularization of the posterior capsule after extracapsular cataract extraction and posterior chamber intraocular lens implantation. The patient was treated with two injections of 2.5 mg of intravitreal bevacizumab. The treatment produced an important regression of the posterior capsular new vessels, allowing us to perform a successful Nd:YAG capsulotomy, clearing the visual axis and improving the visualization of the posterior pole. Even though, best corrected visual acuity was 20/200 due to diabetic macular edema.

Keywords: posterior capsule opacification, posterior capsule neovascularization, cataract surgery, postoperative complications, intravitreal bevacizumab

Other articles by Dr Raul Velez-Montoya

Readers of this article also read: